rs114400071
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_145309.6(LRRC51):c.83-109A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00208 in 1,080,268 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0090 ( 15 hom., cov: 32)
Exomes 𝑓: 0.00095 ( 13 hom. )
Consequence
LRRC51
NM_145309.6 intron
NM_145309.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.91
Publications
0 publications found
Genes affected
LRRC51 (HGNC:55526): (leucine rich repeat containing 51) This gene belongs to the leucine-rich repeat containing family. The encoded protein contains a transmembrane domain and two leucine-rich repeat domains. Unlike in mouse and other mammals, readthrough transcription is observed in primates between this gene and the adjacent transmembrane O-methyltransferase (Tomt) gene. Previously, this locus was annotated as a single gene representing the readthrough transcripts as well as the two different transcript species that encoded different proteins. It has since been split into three genes, including the two stand-alone genes and a third gene representing the readthrough transcription. [provided by RefSeq, Feb 2022]
LRTOMT (HGNC:25033): (leucine rich transmembrane and O-methyltransferase domain containing) This locus represents naturally occurring readthrough transcription between the neighboring LRRC51 (leucine-rich repeat containing 51) and TOMT (transmembrane O-methyltransferase) genes on chromosome 11. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. Multiple reports implicate mutations in this gene in nonsyndromic deafness.[provided by RefSeq, Feb 2021]
LAMTOR1 (HGNC:26068): (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1) Enables GTPase binding activity. Contributes to guanyl-nucleotide exchange factor activity and molecular adaptor activity. Involved in several processes, including cholesterol homeostasis; positive regulation of TOR signaling; and regulation of cholesterol transport. Located in lysosome. Part of Ragulator complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-72093387-A-G is Benign according to our data. Variant chr11-72093387-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 1205440.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00898 (1368/152314) while in subpopulation AFR AF = 0.0314 (1306/41570). AF 95% confidence interval is 0.03. There are 15 homozygotes in GnomAd4. There are 621 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC51 | NM_145309.6 | c.83-109A>G | intron_variant | Intron 3 of 5 | ENST00000289488.8 | NP_660352.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00897 AC: 1365AN: 152196Hom.: 15 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1365
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000949 AC: 881AN: 927954Hom.: 13 AF XY: 0.000827 AC XY: 394AN XY: 476604 show subpopulations
GnomAD4 exome
AF:
AC:
881
AN:
927954
Hom.:
AF XY:
AC XY:
394
AN XY:
476604
show subpopulations
African (AFR)
AF:
AC:
716
AN:
22294
American (AMR)
AF:
AC:
54
AN:
35084
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
22252
East Asian (EAS)
AF:
AC:
0
AN:
33548
South Asian (SAS)
AF:
AC:
2
AN:
69186
European-Finnish (FIN)
AF:
AC:
0
AN:
48248
Middle Eastern (MID)
AF:
AC:
1
AN:
3162
European-Non Finnish (NFE)
AF:
AC:
11
AN:
651878
Other (OTH)
AF:
AC:
97
AN:
42302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
49
98
146
195
244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00898 AC: 1368AN: 152314Hom.: 15 Cov.: 32 AF XY: 0.00834 AC XY: 621AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
1368
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
621
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
1306
AN:
41570
American (AMR)
AF:
AC:
49
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5
AN:
68020
Other (OTH)
AF:
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
77
155
232
310
387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 31, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.